Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/13416
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBellomo, Rinaldoen
dc.contributor.authorMehta, Ren
dc.date.accessioned2015-05-16T03:15:46Z
dc.date.available2015-05-16T03:15:46Z
dc.date.issued1995-11-01en
dc.identifier.citationNew Horizons (baltimore, Md.); 3(4): 760-7en
dc.identifier.govdoc8574607en
dc.identifier.otherPUBMEDen
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/13416en
dc.description.abstractAlthough acute renal failure (ARF) requiring dialysis affects only approximately 4% to 7% of patients admitted to the ICU, such individuals tend to be the sickest and most challenging patients in the ICU. The presence of ARF dramatically complicates their care and mandates the use of extracorporeal renal replacement therapy (RRT). The use of such therapy, with its technical and physiological demands, further complicates treatment. Not surprisingly, therefore, several controversies surround the management of these patients: the techniques of RRT, the indications and timing for their application, the intensity of their use, the selection of suitable patients, the nature of appropriate monitoring and physiologic targets for their application, the type of specialist best suited for the daily management of such patients, the cost-effectiveness of RRT, and the expansion of its use to treat patients without ARF. In many ways, the response to these controversies has diverged between Europe, Australia, and New Zealand on the one hand, and the United States on the other. In this article, we illustrate these sometimes quite different philosophies by presenting two perspectives (from Australia and the United States) on a number of important issues pertaining to RRT.en
dc.language.isoenen
dc.subject.otherAcute Kidney Injury.therapyen
dc.subject.otherCost-Benefit Analysisen
dc.subject.otherDiffusion of Innovationen
dc.subject.otherForecastingen
dc.subject.otherHumansen
dc.subject.otherIntensive Care.organization & administrationen
dc.subject.otherPatient Selectionen
dc.subject.otherRenal Replacement Therapy.economics.methods.trendsen
dc.subject.otherTechnology Assessment, Biomedicalen
dc.titleAcute renal replacement in the intensive care unit: now and tomorrow.en
dc.typeJournal Articleen
dc.identifier.journaltitleNew horizons (Baltimore, Md.)en
dc.identifier.affiliationDepartment of Anaesthesia and Intensive Care, Austin Hospital, Melbourne, Victoria, Australiaen
dc.description.pages760-7en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/8574607en
dc.type.austinJournal Articleen
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeJournal Article-
crisitem.author.deptIntensive Care-
crisitem.author.deptData Analytics Research and Evaluation (DARE) Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

4
checked on Feb 5, 2023

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.